Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Characterization of the Evolution of the Pharmaceutical Regulatory Environment

Nader Shafiei, James L. Ford, Charles W. Morecroft, Paulo J. Lisboa and Mark J. Taylor
PDA Journal of Pharmaceutical Science and Technology July 2013, 67 (4) 297-306; DOI: https://doi.org/10.5731/pdajpst.2013.00930
Nader Shafiei
1School of Pharmacy and Biomolecular Sciences and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n.shafiei@2009.ljmu.ac.uk
James L. Ford
1School of Pharmacy and Biomolecular Sciences and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles W. Morecroft
1School of Pharmacy and Biomolecular Sciences and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulo J. Lisboa
2School of Computing and Mathematical Sciences, Liverpool John Moores University, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Taylor
2School of Computing and Mathematical Sciences, Liverpool John Moores University, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 67 no. 4 297-306
DOI 
https://doi.org/10.5731/pdajpst.2013.00930
PubMed 
23872441

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online July 19, 2013.

Copyright & Usage 
© PDA, Inc. 2013

Author Information

  1. Nader Shafiei1,*,
  2. James L. Ford1,
  3. Charles W. Morecroft1,
  4. Paulo J. Lisboa2 and
  5. Mark J. Taylor2
  1. 1School of Pharmacy and Biomolecular Sciences and
  2. 2School of Computing and Mathematical Sciences, Liverpool John Moores University, Liverpool, UK
  1. ↵* Corresponding Author: Nader Shafiei, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK. E-mail: n.shafiei{at}2009.ljmu.ac.uk
View Full Text

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 67 (4)
PDA Journal of Pharmaceutical Science and Technology
Vol. 67, Issue 4
July/August 2013
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of the Evolution of the Pharmaceutical Regulatory Environment
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Characterization of the Evolution of the Pharmaceutical Regulatory Environment
Nader Shafiei, James L. Ford, Charles W. Morecroft, Paulo J. Lisboa, Mark J. Taylor
PDA Journal of Pharmaceutical Science and Technology Jul 2013, 67 (4) 297-306; DOI: 10.5731/pdajpst.2013.00930

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characterization of the Evolution of the Pharmaceutical Regulatory Environment
Nader Shafiei, James L. Ford, Charles W. Morecroft, Paulo J. Lisboa, Mark J. Taylor
PDA Journal of Pharmaceutical Science and Technology Jul 2013, 67 (4) 297-306; DOI: 10.5731/pdajpst.2013.00930
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1. Introduction
    • 2. Methods
    • 3. Results and Discussion
    • Conflict of Interest Declaration
    • Acknowledgements
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
  • Evaluation of Extreme Depyrogenation Conditions on the Surface Hydrolytic Resistance of Glass Containers for Pharmaceutical Use
  • A Holistic Approach for Filling Volume Variability Evaluation and Control with Statistical Tool
Show more Research

Similar Articles

Keywords

  • Pharmaceutical regulations
  • Pharmaceutical quality
  • Regulatory innovation
  • FDA
  • EMA
  • Public health
  • Crisis management

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire